)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Celularity
Celularity (CELU) investor relations material
Celularity Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary10 Nov, 2026
Executive summary
Annual meeting scheduled for Dec. 30, 2026, at 1:00 p.m. ET, at 170 Park Ave., Florham Park, New Jersey.
Board recommends FOR the director nominee and Proposals 2, 3, 5 and 6; it recommends a 3-year frequency for advisory compensation votes.
Voting matters and shareholder proposals
Shareholders will vote on auditor ratification, advisory executive compensation, the frequency of future advisory compensation votes, an equity plan amendment and approval of financing-related share issuance.
Board of directors and corporate governance
Steven N. Gordon, Esq. is nominated as the sole Class II director, to serve until the 2029 annual meeting and until a successor is elected and qualified, subject to earlier departure.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Celularity
- Shareholders face a major financing-issuance vote, with a 10% price reset if approval misses the deadline.CELU
Proxy filing - Six votes include equity-pool expansion and approval of potentially dilutive financing shares.CELUProxy filing
- One-time gains lifted earnings, but low cash and financing needs kept going-concern risk acute.CELUQ2 2026
- Severe revenue decline and liquidity crisis persist, with going concern risks and Nasdaq non-compliance.CELUQ1 2026
- Severe revenue decline, deep losses, and urgent liquidity needs raise going concern doubts.CELUQ4 2025
- Up to 14.1M shares offered for resale; proceeds possible from warrant exercises, not share sales.CELURegistration Filing
- Resale of up to 15.9M shares targets capital via warrants, amid ongoing losses and high risk.CELURegistration Filing
- Annual meeting to elect director, ratify auditor, and review governance, compensation, and related-party matters.CELUProxy Filing
- Q2 revenue up 312% but severe liquidity and going concern risks persist.CELUQ2 2024
Next Celularity earnings date
Q3 202620 Nov, 2026
Celularity
Next Celularity earnings date
Q3 202620 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Celularity Inc. is a biotechnology company focused on developing off-the-shelf, placental-derived allogeneic cell therapies for treating cancer, immune, and infectious diseases. The company's core therapeutic products include genetically modified and unmodified natural killer (NK) cells, CAR-T cells, and mesenchymal-like adherent stromal cells. Additionally, Celularity produces placental-derived biomaterials used in various therapeutic applications. It operates through three main segments: Cell Therapy, Degenerative Disease, and BioBanking. The company is headquartered in Florham Park, New Jersey, and its shares are listed on NASDAQ.